← Leaderboards
Michael G Kaplitt
Weill Medical College Of Cornell Univ
$3,794,565
Attributed
$6,080,629
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $742.9K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,080,629 · 4
By mechanism
R01$4,941,309 · 2
K08$729,000 · 1
R21$410,320 · 1
Top collaborators
- Jonathan S. Dordick5 shared
- Jeffrey M Friedman5 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Steven S Gross$23,127,784
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisMutantProteinsNeuronsResponseCellsParkinson DiseaseGene DeliveryGene TherapyMouse ModelDependovirusMutationBaseOverexpressionLeadGene ExpressionBehaviorCaspaseNervous System DisorderNeurodegenerative DisordersNerve DegenerationGenesAdultPathway Interactions
Grant awards (17)
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease$660,048
R01 · FY2020 · NS
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease$667,559
R01 · FY2019 · NS
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease$674,954
R01 · FY2018 · NS
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease$683,626
R01 · FY2017 · NS
Remote Electromagnetic Control of Neural Activity for Treatment of Parkinson's Disease$742,909
R01 · FY2016 · NS
XIAP Gene Therapy in Huntington's Disease$349,614
R01 · FY2013 · NS · contact PI
XIAP Gene Therapy in Huntington's Disease$68,323
R01 · FY2013 · NS · contact PI
XIAP Gene Therapy in Huntington's Disease$362,294
R01 · FY2012 · NS · contact PI
XIAP Gene Therapy in Huntington's Disease$362,294
R01 · FY2011 · NS · contact PI
XIAP Gene Therapy in Huntington's Disease$369,688
R01 · FY2010 · NS · contact PI
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity$145,800
K08 · FY2008 · NS · contact PI
Neuroprotection via XIAP gene therapy in Huntington's disease$183,520
R21 · FY2007 · NS · contact PI
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity$145,800
K08 · FY2007 · NS · contact PI
Neuroprotection via XIAP gene therapy in Huntington's disease$226,800
R21 · FY2006 · NS · contact PI
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity$145,800
K08 · FY2006 · NS · contact PI
PTEN Anti-Oncogene Influences on Neuronal Function &Toxicity$145,800
K08 · FY2005 · NS
PTEN Anti-Oncogene: Neuronal Function and Toxicity$145,800
K08 · FY2004 · NS